A Private 16q24.2q24.3 Microduplication in a Boy with Intellectual Disability, Speech Delay and Mild Dysmorphic Features.
Orazio PalumboPietro PalumboEster Di MuroLuigia CinqueAntonio PetraccaMassimo CarellaMarco CastoriPublished in: Genes (2020)
No data on interstitial microduplications of the 16q24.2q24.3 chromosome region are available in the medical literature and remain extraordinarily rare in public databases. Here, we describe a boy with a de novo 16q24.2q24.3 microduplication at the Single Nucleotide Polymorphism (SNP)-array analysis spanning ~2.2 Mb and encompassing 38 genes. The patient showed mild-to-moderate intellectual disability, speech delay and mild dysmorphic features. In DECIPHER, we found six individuals carrying a "pure" overlapping microduplication. Although available data are very limited, genomic and phenotype comparison of our and previously annotated patients suggested a potential clinical relevance for 16q24.2q24.3 microduplication with a variable and not (yet) recognizable phenotype predominantly affecting cognition. Comparing the cytogenomic data of available individuals allowed us to delineate the smallest region of overlap involving 14 genes. Accordingly, we propose ANKRD11, CDH15, and CTU2 as candidate genes for explaining the related neurodevelopmental manifestations shared by these patients. To the best of our knowledge, this is the first time that a clinical and molecular comparison among patients with overlapping 16q24.2q24.3 microduplication has been done. This study broadens our knowledge of the phenotypic consequences of 16q24.2q24.3 microduplication, providing supporting evidence of an emerging syndrome.
Keyphrases
- intellectual disability
- healthcare
- autism spectrum disorder
- ejection fraction
- end stage renal disease
- genome wide
- newly diagnosed
- big data
- electronic health record
- systematic review
- gene expression
- dna methylation
- patient reported outcomes
- case report
- emergency department
- high resolution
- mass spectrometry
- mild cognitive impairment
- multiple sclerosis
- single cell
- human health
- climate change
- risk assessment
- transcription factor
- adverse drug